These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15777990)

  • 21. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
    Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Polymorphisms of CYP1B1 and COMT in breast and endometrial cancer].
    Zimarina TC; Kristensen VN; Imianitov EN; Bershteĭn LM
    Mol Biol (Mosk); 2004; 38(3):386-93. PubMed ID: 15285606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
    Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
    Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
    Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipose tissue PCB levels and CYP1B1 and COMT genotypes in relation to breast cancer risk in postmenopausal Danish women.
    Bräuner EV; Loft S; Wellejus A; Autrup H; Tjønneland A; Raaschou-Nielsen O
    Int J Environ Health Res; 2014; 24(3):256-68. PubMed ID: 23869875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
    Cussenot O; Azzouzi AR; Nicolaiew N; Fromont G; Mangin P; Cormier L; Fournier G; Valeri A; Larre S; Thibault F; Giordanella JP; Pouchard M; Zheng Y; Hamdy FC; Cox A; Cancel-Tassin G
    J Clin Oncol; 2007 Aug; 25(24):3596-602. PubMed ID: 17704407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.
    Hanna IH; Dawling S; Roodi N; Guengerich FP; Parl FF
    Cancer Res; 2000 Jul; 60(13):3440-4. PubMed ID: 10910054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups.
    Al-Hendy A; Salama SA
    J Soc Gynecol Investig; 2006 Feb; 13(2):136-44. PubMed ID: 16443508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
    Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer.
    Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H
    Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of polymorphisms in genes of insulin receptor substrate-1 and enzymes involved in estrogen biosynthesis and metabolism among breast cancer patients with BRCA1 mutations].
    Bershteĭn LM; Ulybina IuM; Pozharisskiĭ KM; Imianitov EN
    Vopr Onkol; 2009; 55(2):158-64. PubMed ID: 19514368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
    Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
    Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
    Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
    Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
    Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of estrogen-related polymorphisms with age at menarche, age at final menstrual period, and stages of the menopausal transition.
    Mitchell ES; Farin FM; Stapleton PL; Tsai JM; Tao EY; Smith-DiJulio K; Woods NF
    Menopause; 2008; 15(1):105-11. PubMed ID: 17589376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
    El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
    Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer risk and polymorphisms in genes involved in metabolism of estrogens (CYP17, HSD17beta1, COMT and MnSOD): possible protective role of MnSOD gene polymorphism Val/Ala and Ala/Ala in women that never breast fed.
    Silva SN; Cabral MN; Bezerra de Castro G; Pires M; Azevedo AP; Manita I; Pina JE; Rueff J; Gaspar J
    Oncol Rep; 2006 Oct; 16(4):781-8. PubMed ID: 16969494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.
    Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF
    Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.